Overview

Biomarker-Directed Therapies

Significance of del(5)(q31q33) in Diseases

Myelodysplastic Syndromes +

Acute Myeloid Leukemia +

Chronic Myelomonocytic Leukemia +

Acute Lymphoblastic Leukemia +

Chronic Myeloid Leukemia +

Hodgkin Lymphoma +

Multiple Myeloma +

Acute Leukemia +

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome +

Anaplastic Large Cell Lymphoma +

Burkitt Lymphoma +

Follicular Lymphoma +

Mantle Cell Lymphoma +

Marginal Zone Lymphoma +

Myelofibrosis +

Refractory Anemia With Excess Blasts +

Acute Biphenotypic Leukemia +

Chronic Lymphocytic Leukemia +

Myeloproliferative Neoplasm +

Non-Hodgkin Lymphoma +

Secondary Myelodysplastic Syndrome +

B-Cell Non-Hodgkin Lymphoma +

Blastic Plasmacytoid Dendritic Cell Neoplasm +

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma +

Lymphoplasmacytic Lymphoma +

Mixed Phenotype Acute Leukemia +

Refractory Anemia With Excess Blasts-2 +

Therapy-Related Acute Myeloid Leukemia +

Therapy-Related Myelodysplastic Syndrome +

Acute Undifferentiated Leukemia +

B-Cell Acute Lymphoblastic Leukemia +

Chronic Myelomonocytic Leukemia-1 +

Diffuse Large B-Cell Lymphoma +

Lymphoblastic Lymphoma +

Lymphoma +

Malignant Solid Tumor +

Mature T-Cell And NK-Cell Neoplasm +

Myelodysplastic/Myeloproliferative Neoplasm +

Plasma Cell Leukemia +

Prolymphocytic Leukemia +

Refractory Anemia With Excess Blasts-1 +

Secondary Acute Myeloid Leukemia +

Acute Bilineal Leukemia +

Acute Myeloid Leukemia With Myelodysplasia-Related Changes +

Acute Promyelocytic Leukemia +

Aggressive Non-Hodgkin Lymphoma +

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative +

B-Cell Prolymphocytic Leukemia +

Chronic Myelomonocytic Leukemia-0 +

Chronic Myelomonocytic Leukemia-2 +

Hematopoietic And Lymphoid Malignancy +

Histiocytic And Dendritic Cell Neoplasm +

Mature B-Cell Lymphoma/Leukemia +

Mediastinal Large B-Cell Lymphoma +

NK-Cell Lymphoma, Unclassifiable +

Primary Myelofibrosis +

Refractory Anemia +

Refractory Anemia With Ring Sideroblasts +

Richter Syndrome +

Small Lymphocytic Leukemia +

Systemic Mastocytosis +

T-Cell Acute Lymphoblastic Leukemia +

T-Cell Lymphoblastic Leukemia/Lymphoma +

T-Cell Non-Hodgkin Lymphoma +

T-Cell And NK-Cell Neoplasm +

Therapy-Related Myeloid Neoplasm +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.